J. J. van Rood

3.5k citations

91 papers · 2.2k indexed · h-index 27

Immunology top 2%
Hematology top 1%
Surgery top 10%
Genetics top 5%
Transplantation top 1%

Co-authors: A. van Leeuwen J. G. Eernisse Frans H.J. Claas B Speck Éliane Gluckman Els Goulmy H. Balner A. Termijtelen
Topics: T-cell and B-cell Immunology (23 papers)Renal Transplantation Outcomes and Treatments (19 papers)Hematopoietic Stem Cell Transplantation (13 papers)
Cited by: Transplantation Hematology Immunology
Journals: Nature The Lancet Journal of Clinical Investigation
Partner nations: Netherlands United Kingdom United States

In The Last Decade

J. J. van Rood

88 papers receiving 2.0k citations

Peers

Countries citing papers authored by J. J. van Rood

Since Specialization

Citations

This map shows the geographic impact of J. J. van Rood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. J. van Rood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. J. van Rood more than expected).

Fields of papers citing papers by J. J. van Rood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. J. van Rood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. J. van Rood. The network helps show where J. J. van Rood may publish in the future.

Co-authorship network of co-authors of J. J. van Rood

This figure shows the co-authorship network connecting the top 25 collaborators of J. J. van Rood. A scholar is included among the top collaborators of J. J. van Rood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. J. van Rood. J. J. van Rood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT 2012 ·Bone Marrow Transplantation ·(unknown),Arjan C. Lankester,Peter A. von dem Borne,Jürgen Kuball,Marc Bierings,Jan J. Cornelissen,(unknown),Bronno van der Holt,Geert W. Haasnoot,(unknown),Suzanna M. van Walraven,J. J. van Rood,Frans H.J. Claas,Machteld Oudshoorn	20
2	Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation 2007 ·Bone Marrow Transplantation ·Martin B.A. Heemskerk,Jan J. Cornelissen,Dave L. Roelen,J. J. van Rood,Frans H.J. Claas,Ilias I.N. Doxiadis,Machteld Oudshoorn	34
3	IgG ANTIBODIES AGAINST AN HLA ANTIGEN ARE ASSOCIATED WITH ACTIVATED CYTOTOXIC T CELLS AGAINST THIS ANTIGEN, IgM ARE NOT 1994 ·Transplantation ·Dave L. Roelen,(unknown),Marian D. Witvliet,(unknown),(unknown),(unknown),Leo P. de Waal,J. J. van Rood,Frans H.J. Claas	31
4	DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506 1993 ·Transplantation ·Dave L. Roelen,(unknown),Urs Schanz,J. J. van Rood,Frans H.J. Claas	26
5	Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. 1993 ·Journal of Clinical Oncology ·Nir I. Weijl,D van der Harst,Anneke Brand,Y Kooy,(unknown),J Schröder,(unknown),J. J. van Rood,F. J. Cleton,Susanne Osanto	71
6	Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis 1993 ·The Lancet ·(unknown),J. D’Amaro,Geziena M. Th. Schreuder,Frans H.J. Claas,J. J. van Rood,S. ten Wolde,F. C. Breedveld,Pablo Rubinstein	44
7	Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. 1992 ·PubMed ·J. Thorogood,G. M. T. Schreuder,Guido G. Persijn,J. J. van Rood	2
8	Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells. 1991 ·The Journal of Experimental Medicine ·W. A. Erik Marijt,W. F. J. Veenhof,Anneke Brand,E Goulmy,WE Fibbe,Roel Willemze,J. J. van Rood,J.H.F. Falkenburg	35
9	EFFECTOR MECHANISMS IN GRAFT-VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS 1990 ·Transplantation ·Cécile A. C. M. van,(unknown),Aeilko H. Zwinderman,F. E. Zwaan,J. J. van Rood,E Goulmy	43
10	SEROLOGICAL AND MOLECULAR STUDIES OF EPSTEIN-BARR VIRUS INFECTION IN ALLOGENEIC MARROW GRAFT RECIPIENTS 1990 ·Transplantation ·Jan W. Gratama,M. A. P. Oosterveer,(unknown),J. J. van Rood,F. E. Zwaan,J M Vossen,Jacoba G. Kapsenberg,D. J. Richel,Georg Klein,Ingemar Ernberg	31
11	EFFECTOR MECHANISMS IN GRAFT-VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS 1990 ·Transplantation ·Cécile A. C. M. van,(unknown),Aeilko H. Zwinderman,F. E. Zwaan,J. J. van Rood,E Goulmy	46
12	Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens 1990 ·The Lancet ·(unknown),(unknown),Willem E. Fibbe,Erik W.A. Marijt,W. F. J. Veenhof,Malcolm Hamilton,F. E. Zwaan,Rein Willemze,JH Falkenburg,P.J. Voogt,Els Goulmy,Anneke Brand,J. J. van Rood	86
13	RENAL TRANSPLANT PATIENTS MONITORED BY THE CELL-MEDIATED LYMPHOLYSIS ASSAY 1989 ·Transplantation ·Els Goulmy,(unknown),(unknown),Guido G. Persijn,Els Blokland,(unknown),L. C. Paul,J. J. van Rood	39
14	Host-directed cytotoxic activity in bone marrow-grafted patients. 1985 ·Transplantation Proceedings ·Els Goulmy,Els Blokland,(unknown),F. E. Zwaan,J. J. van Rood	5
15	Antibodies to endothelial antigens in eluates of 88 human kidneys: correlation with graft survival and presence of T- and B-cell antibodies. 1981 ·PubMed ·William M. Baldwin,Jean‐Paul Soulillou,F.H.J. Claas,Marie‐Alix Peyrat,Leendert A. van Es,J. J. van Rood	19
16	Antibodies against Donor Antigens on Endothelial Cells and Monocytes in Eluates of Rejected Kidney Allografts 1980 ·Tissue Antigens ·F.H.J. Claas,Leendert C. Paul,Leendert A. van Es,J. J. van Rood	27
17	HLA-D, -DR clinical significance. A new strategy to improve kidney graft survival 1979 ·Transplantation Proceedings ·E Goulmy,J. J. van Rood,G. G. Persijn,Astrid van Leeuwen,B.W. Gabb	6
18	The Effect of Antithymocyte Globulin on Abnormal Lymphocyte Transformation in Patients with Aplastic Anemia 1979 ·Hämatologie und Bluttransfusion ·L. Sabbe,H. L. Haak,B. A. Bradley,J. J. van Rood	2
19	SEROTYPING FOR MLC. II. TECHNICAL ASPECTS* 1975 ·Annals of the New York Academy of Sciences ·A. van Leeuwen,R. J. Winchester,J. J. van Rood	13
20	Histocompatibility and Heterotopic Segmental Small Bowel Allograft Survival in Dogs 1970 ·European Surgical Research ·D.L. Westbroek,(unknown),H. M. Vriesendorp,J. J. van Rood	6

About J. J. van Rood

J. J. van Rood is a scholar working on Transplantation, Hematology and Immunology, having authored 91 papers that have together received 2.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (23 papers), Renal Transplantation Outcomes and Treatments (19 papers) and Hematopoietic Stem Cell Transplantation (13 papers). The work is most often cited by research in Transplantation (305 citations), Hematology (650 citations) and Immunology (1.1k citations). J. J. van Rood has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include A. van Leeuwen, J. G. Eernisse, Frans H.J. Claas, B Speck, Éliane Gluckman, Els Goulmy, H. Balner, A. Termijtelen, F.H.J. Claas and E Goulmy. Their work appears in journals such as Nature, The Lancet and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact